1994
DOI: 10.1001/archderm.130.5.589
|View full text |Cite
|
Sign up to set email alerts
|

CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

5
66
2
3

Year Published

2001
2001
2020
2020

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 72 publications
(76 citation statements)
references
References 0 publications
5
66
2
3
Order By: Relevance
“…These differences are widely independent of the anatomical site and histological type of carcinoma and consist of a loss of CD34 + fibrocytes and a subsequent gain of a-smooth muscle antigen (SMA)-positive myofibroblasts [2,3,4,6,12,17]. CD34 + fibrocytes appear to be constitutive elements of the connective tissue in a multitude of anatomical sites, such as the skin [12], the breast [3,6], the gastrointestinal tract [2,14,15], and the cervix [4]. In all of the aforementioned locations, the stroma of invasive carcinomas discloses a reduction or complete loss of CD34 + fibrocytes paralleled by the occurrence of a-SMApositive myofibroblasts [2,3,4,6,12,17].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…These differences are widely independent of the anatomical site and histological type of carcinoma and consist of a loss of CD34 + fibrocytes and a subsequent gain of a-smooth muscle antigen (SMA)-positive myofibroblasts [2,3,4,6,12,17]. CD34 + fibrocytes appear to be constitutive elements of the connective tissue in a multitude of anatomical sites, such as the skin [12], the breast [3,6], the gastrointestinal tract [2,14,15], and the cervix [4]. In all of the aforementioned locations, the stroma of invasive carcinomas discloses a reduction or complete loss of CD34 + fibrocytes paralleled by the occurrence of a-SMApositive myofibroblasts [2,3,4,6,12,17].…”
Section: Introductionmentioning
confidence: 99%
“…CD34 + fibrocytes appear to be constitutive elements of the connective tissue in a multitude of anatomical sites, such as the skin [12], the breast [3,6], the gastrointestinal tract [2,14,15], and the cervix [4]. In all of the aforementioned locations, the stroma of invasive carcinomas discloses a reduction or complete loss of CD34 + fibrocytes paralleled by the occurrence of a-SMApositive myofibroblasts [2,3,4,6,12,17]. In addition to their function as matrix-producing [5,8] and antigenpresenting cells [7], CD34 + fibrocytes secrete plateletderived growth factor (PDGF) [10], the receptor of which, c-kit (CD117), a protein receptor with tyrosine kinase activity, is structurally identical to that of stem cell factor (SCF).…”
Section: Introductionmentioning
confidence: 99%
“…They are believed to play a supportive role in the maturation and proliferation of adjacent cells. These cells have been studied only in the field of dermatopathology [2,3,8,11] and in the stroma of a few tumors such as major salivary gland pleomorphic adenoma [6] and gastric adenocarcinoma [9,12]. However, their distribution and role in organized lymphoid tissue such as that in palatine tonsils has not been studied to date.…”
Section: Introductionmentioning
confidence: 99%
“…Introduction CD34 + fibrocytes have been detected in normal skin [16], normal breast tissue [4,20,24], and in various cutaneous [5,6,9,10,23] and mesenchymal tumors [13,17,19,20,21,22]. To date, the origin of this cell population remains enigmatic, but experimental studies support the assumption that CD34 + fibrocytes derive from myeloid precursors [2].…”
mentioning
confidence: 99%